Related Experiment Video
Updated: Feb 7, 2026

Expression, Purification, and Antimicrobial Activity of S100A12
Published on: May 13, 2017
In vitro antimicrobial activity of monensin against common clinical isolates associated with canine otitis externa
Wei Yee Chan1, Elizabeth E Hickey1, Manouchehr Khazandi1
1Australian Centre for Antimicrobial Resistance Ecology, School of Animal and Veterinary Sciences, The University of Adelaide, Roseworthy Campus, Mudla Wirra Rd, Roseworthy, SA 5371, Australia.
Abstract:
Antimicrobial resistance and antimicrobial stewardship are of ever-increasing importance in veterinary medicine. Multidrug-resistant infections of the canine skin and ear continue to emerge, but the use of antibiotic classes of critical importance to human medicine may not represent good antimicrobial stewardship. Repurposing of old drugs that are not used in human medicine is one approach that addresses both these issues. In this study, the minimal inhibitory concentration (MIC) of monensin for 111 bacterial and yeast canine otitis isolates was determined using microdilution methodology according to Clinical Laboratory Standards Institute (CLSI) guidelines. Monensin was effective against all Gram-positive bacteria including the multidrug-resistant staphylococcal strains with MICs ranging from 1 to 4 μg/ml, but lacked antimicrobial activity against Gram-negative bacteria and yeast isolates. Monensin has potential to be incorporated as one of the main components in an otic formulation.
Insights
Monensin shows promise for treating canine ear infections caused by Gram-positive bacteria, including multidrug-resistant strains. This study evaluated its effectiveness, offering a potential solution for antimicrobial stewardship in veterinary medicine.
Area of Science:
- Veterinary Medicine
- Microbiology
- Pharmacology
Background:
- Antimicrobial resistance is a growing concern in veterinary medicine.
- Multidrug-resistant infections in dogs necessitate alternative treatment strategies.
- Repurposing older drugs not critical for human medicine is a key approach to antimicrobial stewardship.
Purpose of the Study:
- To determine the antimicrobial activity of monensin against canine otitis isolates.
- To evaluate monensin's potential as a therapeutic agent for canine ear infections.
Main Methods:
- Minimal inhibitory concentration (MIC) of monensin was determined for 111 bacterial and yeast canine otitis isolates.
- Microdilution methodology was employed following Clinical Laboratory Standards Institute (CLSI) guidelines.
Main Results:
- Monensin demonstrated effectiveness against all Gram-positive bacteria, including multidrug-resistant staphylococcal strains, with MICs between 1-4 μg/ml.
- Monensin exhibited no antimicrobial activity against Gram-negative bacteria or yeast isolates.
Conclusions:
- Monensin is a viable candidate for treating Gram-positive bacterial infections in canine otitis.
- Monensin has potential for inclusion in otic formulations for veterinary use.
Related Concept Videos
Common Ion Effect
Antimicrobial Effectiveness
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Common Respiratory Disorders
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Mass Analyzers: Common Types
Common Leveling Mistakes and Errors

